US Patent Issued to Regeneron Pharmaceuticals on Feb. 24 for "CD20-PD1 binding molecules and methods of use thereof" (New York Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,576, issued on Feb. 24, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"CD20-PD1 binding molecules and methods of use thereof" was invented by Yang Shen (Scarsdale, N.Y.), Bei Wang (Hastings-on-Hudson, N.Y.), Naga Suhasini Avvaru (Briarcliff Manor, N.Y.), Chia-Yang Lin (Scarsdale, N.Y.), Andrew Murphy (Croton-on-Hudson, N.Y.), Aynur Hermann (New York) and Jee H. Kim (Ardsley, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to molecules capable of binding to both CD20 and PD1, as well as pharmaceutical compositions comprising such molecules and methods of use thereof."

The patent was filed on Nov...